SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Helinto M,Blomqvist C,Heikkila P, et al. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? Radiother Oncol. 1999; 52: 213217.
  • 2
    Overgaard M,Hansen PR,Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997; 337: 949955.
  • 3
    Overgaard M,Jensen MB,Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet. 1999; 353: 16411648.
  • 4
    Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005; 366: 20872106.
  • 5
    Jagsi R,Raad RA,Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005; 62: 10351039.
  • 6
    Floyd SR,Buchholz TA,Haffty BG, et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys. 2006; 66: 358364.
  • 7
    Taghian AG,Jeong JH,Manmouas EP, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2006; 24: 39273932.
  • 8
    Carlson RW,Anderson BO,Burstein HJ, et al. NCCN breast cancer clinical practice guidelines in oncology. Version 1, 2007. Available at http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf Accessed September 8, 2007.
  • 9
    Rosenbaum PR,Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983; 70: 4155.
  • 10
    Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997; 127: 757763.
  • 11
    Smith BD,Smith GL,Haffty BG. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol. 2005; 23: 14091419.
  • 12
    Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Limited-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
  • 13
    FritzA,PercyC,JackA,SobinLH,ParkinMD (eds.). International Classification of Diseases for Oncology (ed. 3). Geneva: World Health Organization; 2000.
  • 14
    Leuven E,Sianesi B. “PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing.” 2003. Available at: http://ideas.repec.org/c/boc/bocode/s432001.html Version 3.0.0. Accessed September 12, 2007.
  • 15
    Rosenbaum PR,Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985; 39: 3338
  • 16
    Carey LA,Perou CM,Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 2492502.
  • 17
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 16871717.